These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8949685)

  • 1. Evaluation of palpable breast masses with 201TI scintigraphy.
    Roebuck DJ
    Br J Radiol; 1996 Aug; 69(824):785-6. PubMed ID: 8949685
    [No Abstract]   [Full Text] [Related]  

  • 2. Thallium scintigraphy in the evaluation of mass abnormalities of the breast.
    Waxman AD; Ramanna L; Memsic LD; Foster CE; Silberman AW; Gleischman SH; Brenner RJ; Brachman MB; Kuhar CJ; Yadegar J
    J Nucl Med; 1993 Jan; 34(1):18-23. PubMed ID: 8418263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of palpable breast masses with 201Tl scintigraphy.
    Rebollo AC; Torres-Avisbal M; Espinosa JE; Diaz C; Vallejo JA; Pacheco C; Pera C; Mateo A
    Br J Radiol; 1995 Oct; 68(814):1052-7. PubMed ID: 7496703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 201Tl scintigraphy in the evaluation of palpable and nonpalpable breast lesions: correlation with mammography and ultrasonography.
    Vural G; Atasever T; Ozdemir A; Oznur I; Karabacak NI; Gökçora N; Işik S; Unlü M
    Nuklearmedizin; 1997 Dec; 36(8):282-8. PubMed ID: 17068879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midcourse thallium-201 scintigraphy to predict tumor response in bone and soft-tissue tumors.
    Sumiya H; Taki J; Tsuchiya H; Nonomura A; Miyauchi T; Tonami N
    J Nucl Med; 1998 Sep; 39(9):1600-4. PubMed ID: 9744351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technetium-99m-sestamibi imaging in breast cancer: an alternative to thallium-201 imaging.
    Aktolun C
    J Nucl Med; 1994 Dec; 35(12):2055-6. PubMed ID: 7989994
    [No Abstract]   [Full Text] [Related]  

  • 7. Thallium-201 scintigraphy in differentiated thyroid cancer: comparison with radioiodine scintigraphy and serum thyroglobulin determinations.
    Ramanna L; Waxman A; Braunstein G
    J Nucl Med; 1991 Mar; 32(3):441-6. PubMed ID: 2005453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up study of postoperative patients with thyroid cancer by thallium-201 scintigraphy and serum thyroglobulin measurement.
    Iida Y; Hidaka A; Hatabu H; Kasagi K; Konishi J
    J Nucl Med; 1991 Nov; 32(11):2098-100. PubMed ID: 1941144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast carcinomas detected by thallium-201 scintigraphy.
    Sluyser M; Hoefnagel CA
    Cancer Lett; 1988 Jun; 40(2):161-8. PubMed ID: 3383174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scintimammography (SMM) in breast cancer patients.
    Mangkharak J
    J Med Assoc Thai; 1999 Mar; 82(3):242-9. PubMed ID: 10410478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thallium-201 scintigraphy of the suppressed thyroid: an alternative for iodine-123 scanning after TSH stimulation.
    Corstens F; Huysmans D; Kloppenborg P
    J Nucl Med; 1988 Aug; 29(8):1360-3. PubMed ID: 3404253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 201ti scintigraphy in postoperative detection of thyroid cancer: a comparative study with 131i.
    Tonami N; Hisada K
    Radiology; 1980 Aug; 136(2):461-4. PubMed ID: 7403524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of differential diagnostic capabilities of 201Tl scintigraphy and fine-needle aspiration of thyroid nodules.
    Okumura Y; Takeda Y; Sato S; Komatsu M; Nakagawa T; Akaki S; Kuroda M; Joja I; Hiraki Y
    J Nucl Med; 1999 Dec; 40(12):1971-7. PubMed ID: 10616873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technetium-99m-sestamibi scintigraphy compared with thallium-201 in evaluation of thyroid tumors.
    Nakahara H; Noguchi S; Murakami N; Hoshi H; Jinnouchi S; Nagamachi S; Ohnishi T; Futami S; Flores LG; Watanabe K
    J Nucl Med; 1996 Jun; 37(6):901-4. PubMed ID: 8683308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent medullary carcinoma of the thyroid demonstrated by thallium-201 scintigraphy.
    Arnstein NB; Juni JE; Sisson JC; Lloyd RV; Thompson NW
    J Nucl Med; 1986 Oct; 27(10):1564-8. PubMed ID: 3760981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating benign and malignant bone and soft-tissue lesions with technetium-99m-MIBI scintigraphy.
    Taki J; Sumiya H; Tsuchiya H; Tomita K; Nonomura A; Tonami N
    J Nucl Med; 1997 Apr; 38(4):501-6. PubMed ID: 9098190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of MIBI breast scintigraphy in evaluation of palpable breast lesions.
    Lam WW; Yang WT; Chan YL; Stewart IE; King W; Metreweli C
    Br J Radiol; 1996 Dec; 69(828):1152-8. PubMed ID: 9135472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A complementary role for thallium-201 scintigraphy with mammography in the diagnosis of breast cancer.
    Lee VW; Sax EJ; McAneny DB; Pollack S; Blanchard RA; Beazley RM; Kavanah MT; Ward RJ
    J Nucl Med; 1993 Dec; 34(12):2095-100. PubMed ID: 8254394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship among 201T1 uptake, nuclear DNA content and clinical behavior in metastatic thyroid carcinoma.
    Nakada K; Katoh C; Morita K; Kanegae K; Tsukamoto E; Shiga T; Mochizuki T; Tamaki N
    J Nucl Med; 1999 Jun; 40(6):963-7. PubMed ID: 10452311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thallium-201 scintigraphy in bone sarcoma: comparison with gallium-67 and technetium-MDP in the evaluation of chemotherapeutic response.
    Ramanna L; Waxman A; Binney G; Waxman S; Mirra J; Rosen G
    J Nucl Med; 1990 May; 31(5):567-72. PubMed ID: 2341892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.